Ganga Pharmaceuticals Limited (BOM:539680)
India
· Delayed Price · Currency is INR 12.00
0.00 (0.00%)
At close: Feb 12, 2026
Ganga Pharmaceuticals Revenue
Ganga Pharmaceuticals had revenue of 13.67M INR in the half year ending September 30, 2025, with 3.57% growth. This brings the company's revenue in the last twelve months to 26.93M, down -1.29% year-over-year. In the fiscal year ending March 31, 2025, Ganga Pharmaceuticals had annual revenue of 26.37M, down -3.60%.
Revenue (ttm)
26.93M
Revenue Growth
-1.29%
P/S Ratio
2.63
Revenue / Employee
1.58M
Employees
17
Market Cap
70.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.37M | -984.21K | -3.60% |
| Mar 31, 2024 | 27.36M | 1.49M | 5.78% |
| Mar 31, 2023 | 25.86M | 973.18K | 3.91% |
| Mar 31, 2022 | 24.89M | 1.15M | 4.83% |
| Mar 31, 2021 | 23.74M | -7.04M | -22.88% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Brawn Biotech | 172.71M |
| Decipher Labs | 148.66M |
| Vivanza Biosciences | 1.10B |
| Unjha Formulations | 148.12M |
| Beryl Drugs | 176.65M |
| Colinz Laboratories | 58.40M |
| Ortin Global | 1.12M |
| Fabino Enterprises | 204.36M |